PRESS RELEASE published on 12/09/2024 at 07:30, 1 year 9 months ago Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement Crossject and the U.S. Department of Defense extend their cooperative research on needle-free autoinjectors, aiming to provide life-saving treatment in extreme conditions Crossject U.S. Department Of Defense Needle-free Autoinjectors Cooperative Research Emergency Treatment
BRIEF published on 08/22/2024 at 07:35, 2 years 1 month ago Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright Investissement Conference H.C. Wainwright Crossject ZENEO®
BRIEF published on 08/22/2024 at 07:35, 2 years 1 month ago Crossject to Participate in HC Wainwright’s 26th Annual Global Investment Conference Investment Conference Crossject ZENEO® HC Wainwright
PRESS RELEASE published on 08/22/2024 at 07:30, 2 years 1 month ago Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024 Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright du 9 au 11 septembre 2024, présentant son auto-injecteur primé ZENEO® pour les urgences médicales Conference Crossject ZENEO® Investissement Global Auto-injecteur
PRESS RELEASE published on 08/22/2024 at 07:30, 2 years 1 month ago Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024 Crossject to present at H.C. Wainwright 26th Annual Global Investment Conference on September 9th-11th, 2024, showcasing their needle-free auto-injector ZENEO® H.C. Wainwright Crossject Needle-free Auto-injector ZENEO® Global Investment Conference
BRIEF published on 07/18/2024 at 07:35, 2 years 2 months ago Crossject Achieves Key ZEPIZURE® Manufacturing Milestone Crossject ZEPIZURE® Manufacturing Milestone FDA EUA ZENEO®
BRIEF published on 07/18/2024 at 07:35, 2 years 2 months ago Crossject franchit une étape clé dans la fabrication de ZEPIZURE® ZEPIZURE® Projet Croisé ZENEO® Jalon De Fabrication EUA FDA
PRESS RELEASE published on 07/18/2024 at 07:30, 2 years 2 months ago Crossject achieves key ZEPIZURE® manufacturing milestone Crossject achieves key ZEPIZURE manufacturing milestone with successful completion of new registration batch at Eurofins' qualified facility, supporting EUA timelines Emergency Use Authorization Crossject ZEPIZURE Eurofins Manufacturing Milestone
BRIEF published on 06/26/2024 at 07:35, 2 years 3 months ago Crossject souligne le potentiel de ZEPIZURE® à la suite des études RAMPART et de bioéquivalence Crossject ZEPIZURE® Midazolam Étude RAMPART Crises Épileptiques
BRIEF published on 06/26/2024 at 07:35, 2 years 3 months ago Crossject highlights the potential of ZEPIZURE® following RAMPART and bioequivalence studies Crossject ZEPIZURE® Midazolam RAMPART Study Epileptic Seizures
Published on 10/07/2026 at 17:00, 3 hours 10 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 4 hours 40 minutes ago Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 5 hours 40 minutes ago Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/07/2026 at 13:33, 6 hours 37 minutes ago BULGOLD Samples 21.2g/t Gold at Surface and Expands Kopernica Footprint by 170% to 1,700 Metres by 800 Metres, Lutila Project
Published on 10/07/2026 at 13:00, 7 hours 10 minutes ago ATHA Energy Successfully Completes Diamond Drilling at RIB North Discovery, Expanding Strike Length To 3.4 Km, And Identifies a Higher-Grade Sub Zone: Results Include RIBN-DD-023 Intersecting 19.5 M Of Composite Uranium Mineralization With 2.0 M Of High-G
Published on 10/07/2026 at 18:30, 1 hour 40 minutes ago IEVA GROUP: rappel – Visioconference actionnaires et investisseurs jeudi 15 octobre 2026 - 18h00 (CEST)
Published on 10/07/2026 at 18:15, 1 hour 55 minutes ago VAZIVA SA: 2026 HALF-YEAR RESULTS - A half-year of strategic investments to prepare a new growth cycle
Published on 10/07/2026 at 18:00, 2 hours 10 minutes ago EUROPLASMA: Réduction de capital et regroupement des actions Europlasma
Published on 10/07/2026 at 17:44, 2 hours 25 minutes ago BILENDI: Half-year 2026 Results: Continued execution of the strategic plan in a challenging market environment
Published on 10/07/2026 at 17:44, 2 hours 25 minutes ago BILENDI: Résultats semestriels 2026 : Poursuite de l’exécution du plan stratégique dans un environnement de marché exigeant
Published on 10/07/2026 at 18:19, 1 hour 50 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 18:19, 1 hour 50 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 septembre 2026
Published on 10/07/2026 at 18:00, 2 hours 10 minutes ago Mint organise une visioconférence pour annoncer ses résultats semestriels 2026.
Published on 10/07/2026 at 18:00, 2 hours 10 minutes ago Cegedim Assurances et Shift Technology fêtent 5 ans de partenariat et intègrent WTW au sein de leur dispositif commun de lutte contre la fraude
Published on 10/07/2026 at 18:00, 2 hours 10 minutes ago LDC : Chiffre d’affaires du 1er semestre 2026-2027.